VSTM
Price
$8.61
Change
-$0.58 (-6.31%)
Updated
Sep 24 closing price
Capitalization
529.9M
XCUR
Price
$4.25
Change
+$0.74 (+21.08%)
Updated
Sep 24 closing price
Capitalization
26.85M
Interact to see
Advertisement

VSTM vs XCUR

Header iconVSTM vs XCUR Comparison
Open Charts VSTM vs XCURBanner chart's image
Verastem
Price$8.61
Change-$0.58 (-6.31%)
Volume$1.62M
Capitalization529.9M
Exicure
Price$4.25
Change+$0.74 (+21.08%)
Volume$46.06K
Capitalization26.85M
VSTM vs XCUR Comparison Chart in %
Loading...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XCUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VSTM vs. XCUR commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSTM is a Buy and XCUR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (VSTM: $8.61 vs. XCUR: $4.25)
Brand notoriety: VSTM and XCUR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VSTM: 59% vs. XCUR: 96%
Market capitalization -- VSTM: $529.9M vs. XCUR: $26.85M
VSTM [@Biotechnology] is valued at $529.9M. XCUR’s [@Biotechnology] market capitalization is $26.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VSTM’s FA Score shows that 0 FA rating(s) are green whileXCUR’s FA Score has 0 green FA rating(s).

  • VSTM’s FA Score: 0 green, 5 red.
  • XCUR’s FA Score: 0 green, 5 red.
According to our system of comparison, both VSTM and XCUR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VSTM’s TA Score shows that 4 TA indicator(s) are bullish while XCUR’s TA Score has 6 bullish TA indicator(s).

  • VSTM’s TA Score: 4 bullish, 5 bearish.
  • XCUR’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, XCUR is a better buy in the short-term than VSTM.

Price Growth

VSTM (@Biotechnology) experienced а -8.79% price change this week, while XCUR (@Biotechnology) price change was +19.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.77%. For the same industry, the average monthly price growth was +8.47%, and the average quarterly price growth was +51.69%.

Industries' Descriptions

@Biotechnology (+0.77% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VSTM($530M) has a higher market cap than XCUR($26.9M). VSTM YTD gains are higher at: 66.538 vs. XCUR (-68.910). XCUR has higher annual earnings (EBITDA): -12.42M vs. VSTM (-163.52M). VSTM has more cash in the bank: 164M vs. XCUR (7.86M). XCUR has less debt than VSTM: XCUR (476K) vs VSTM (84.7M). VSTM has higher revenues than XCUR: VSTM (2.14M) vs XCUR (0).
VSTMXCURVSTM / XCUR
Capitalization530M26.9M1,970%
EBITDA-163.52M-12.42M1,316%
Gain YTD66.538-68.910-97%
P/E RatioN/A0.19-
Revenue2.14M0-
Total Cash164M7.86M2,087%
Total Debt84.7M476K17,794%
FUNDAMENTALS RATINGS
VSTM vs XCUR: Fundamental Ratings
VSTM
XCUR
OUTLOOK RATING
1..100
1150
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
35
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
3696
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XCUR's Valuation (35) in the null industry is somewhat better than the same rating for VSTM (74) in the Biotechnology industry. This means that XCUR’s stock grew somewhat faster than VSTM’s over the last 12 months.

XCUR's Profit vs Risk Rating (100) in the null industry is in the same range as VSTM (100) in the Biotechnology industry. This means that XCUR’s stock grew similarly to VSTM’s over the last 12 months.

XCUR's SMR Rating (99) in the null industry is in the same range as VSTM (100) in the Biotechnology industry. This means that XCUR’s stock grew similarly to VSTM’s over the last 12 months.

VSTM's Price Growth Rating (36) in the Biotechnology industry is somewhat better than the same rating for XCUR (96) in the null industry. This means that VSTM’s stock grew somewhat faster than XCUR’s over the last 12 months.

VSTM's P/E Growth Rating (100) in the Biotechnology industry is in the same range as XCUR (100) in the null industry. This means that VSTM’s stock grew similarly to XCUR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VSTMXCUR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 15 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XCUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYTSX57.840.07
+0.12%
Rydex Transportation A
GCVRX24.99-0.06
-0.24%
Goldman Sachs Large Cp Val Insghts R
BHSRX57.14-0.20
-0.35%
BlackRock Health Sciences Opps R
SDVRX26.74-0.10
-0.37%
PGIM Quant Solutions Mid-Cap Val R
NWHZX75.09-1.01
-1.33%
Nationwide Geneva Small Cap Gr A

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with NKTX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
-6.31%
NKTX - VSTM
36%
Loosely correlated
+0.98%
SYRE - VSTM
36%
Loosely correlated
+6.12%
TVRD - VSTM
33%
Loosely correlated
-1.15%
TERN - VSTM
32%
Poorly correlated
+4.79%
IMNM - VSTM
32%
Poorly correlated
+6.06%
More

XCUR and

Correlation & Price change

A.I.dvisor tells us that XCUR and VSTM have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XCUR and VSTM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XCUR
1D Price
Change %
XCUR100%
+21.08%
VSTM - XCUR
28%
Poorly correlated
-6.31%
AMGXF - XCUR
27%
Poorly correlated
N/A
NBY - XCUR
25%
Poorly correlated
+0.93%
ERNA - XCUR
23%
Poorly correlated
-6.61%
FBRX - XCUR
23%
Poorly correlated
-5.42%
More